Clinical Trials Logo

Arterial Embolization clinical trials

View clinical trials related to Arterial Embolization.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02248688 Completed - Obesity Clinical Trials

Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically

GETLEAN
Start date: September 2014
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to achieve the collection of safety and efficacy data in patients undergoing left gastric artery embolization for morbid obesity in the United States. As secondary goal, the pilot study seeks to obtain quality of life data. This pilot study is not designed to achieve new indications for this device.

NCT ID: NCT01852734 Completed - Uterine Fibroids Clinical Trials

Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives

Start date: November 2013
Phase: N/A
Study type: Interventional

The purpose of this prospective non-randomised study is to examine whether two different microspheres (Bead-Block and Embosphere) are equally effective in the treatment of the uterine fibroid controlled with contrast-enhanced MR examination. Quantitative MR imaging, including dominant fibroid T1, T2 and contrast enhancement characteristics before intervention and 3 months after interventions will be analysed as a potential predictor of volumetric response after embolization. Another purpose is to determine long-term follow-up in all patient treated in a period from 2001-2011 in OUH analysed retrospectively.

NCT ID: NCT01142180 Completed - Bleeding Clinical Trials

Early Selective TAE to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis

Start date: January 2010
Phase: N/A
Study type: Interventional

The aim of this study is to determine if early angiographic embolization can forestall recurrent bleeding in selected high risk ulcers after their initial endoscopic control; to validate prospectively the investigators proposed in selecting high risk ulcers for recurrent bleeding in spite of maximal endoscopic control and profound acid suppression using high dose intravenous infusion of proton pump inhibitor; to characterize the nature of bleeding arteries in severely bleeding peptic ulcers and determine the efficacy of angiographic embolization in the prevention of recurrent bleeding and to establish safety profile of angiographic embolization as an early elective treatment to bleeding peptic ulcers.